{
    "nctId": "NCT04339517",
    "briefTitle": "Postoperative Identification of Tumor Cells at the Lumpectomy Site of Patients With Early Breast Cancer",
    "officialTitle": "Postoperative Identification of Tumor Cells at the Lumpectomy Site of Patients With Early Breast Cancer",
    "overallStatus": "SUSPENDED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Identification of Persistent Tumor Cells (PTCs)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women with pathologic stage I to IIB invasive mammary breast cancer.\n2. Tumor size over 1 cm.\n3. Patient age 50 years or younger.\n4. Primary tumor non-lobular.\n5. Primary tumor non-low grade or Oncotype DX score \\> 18.\n6. Patient is six weeks or earlier post-lumpectomy.\n7. Seroma is clinically palpable and symptomatic causing discomfort and/or swelling of the lumpectomy site OR re-excision of the lumpectomy site is planned.",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT"
}